A review of the value of d-dimer testing for prediction of recurrent venous thromboembolism with increasing age

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 6, 2014, Pages 634-639

  Lippi, Giuseppe ^a   Favaloro, Emmanuel J ^b   Cervellin, Gianfranco ^c  

^a UO Diagnostica Ematochimica   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

^c ACADEMIC HOSPITAL OF PARMA   (Italy)

Author keywords

aging; D dimer; older people; thrombosis; venous thromboembolism

Indexed keywords

FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

AGE; AGED; AGING; BLOOD; HUMAN; MIDDLE AGED; RISK FACTOR; THROMBOSIS; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MIDDLE AGED; RISK FACTORS; THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84939887950     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1384630     Document Type: Article

References (33)

1. Deitelzweig S. B., Johnson B. H., Lin J., Schulman K. L. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol: 2011; 86 2 217 220
2. Montagnana M., Favaloro E. J., Franchini M., Guidi G. C., Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis: 2010; 29 4 489 496
3. White R. H. The epidemiology of venous thromboembolism. Circulation: 2003; 107 23 01 I4 I8
4. Lippi G., Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost: 2008; 34 8 747 761
5. Lippi G., Franchini M., Favaloro E. J. Unsuspected triggers of venous thromboembolism-trivial or not so trivial? Semin Thromb Hemost: 2009; 35 7 597 604
6. Lippi G., Franchini M., Favaloro E. J. Holiday thrombosis. Semin Thromb Hemost: 2011; 37 8 869 874
7. Favaloro E. J., Franchini M., Lippi G. Coagulopathies and thrombosis: usual and unusual causes and associations. Part V. Semin Thromb Hemost: 2011; 37 8 859 862
8. Silverstein R. L., Bauer K. A., Cushman M., Esmon C. T., Ershler W. B., Tracy R. P. Venous thrombosis in the elderly: more questions than answers. Blood: 2007; 110 9 3097 3101
9. Spencer F. A., Gore J. M., Lessard D., et al. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost: 2008; 100 5 780 788
10. López-Jiménez L., Montero M., González-Fajardo J. A., et al. RIETE Investigators. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE). Haematologica: 2006; 91 8 1046 1051
11. Piazza G., Seddighzadeh A., Goldhaber S. Z. Deep-vein thrombosis in the elderly. Clin Appl Thromb Hemost: 2008; 14 4 393 398
12. Engbers M. J., van Hylckama Vlieg A., Rosendaal F. R. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost: 2010; 8 10 2105 2112
13. Bauer K. A., Weiss L. M., Sparrow D., Vokonas P. S., Rosenberg R. D. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest: 1987; 80 6 1527 1534
14. Bates S. M. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost: 2012; 38 7 673 682
15. Lippi G., Cervellin G., Casagranda I., Morelli B., Testa S., Tripodi A. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med: 2014; 52 5 621 628
16. Lippi G., Favaloro E. J. D-dimer measurement and laboratory feedback. J Emerg Med: 2009; 37 1 82 83, author reply 83
17. Lippi G., Bonfanti L., Saccenti C., Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med: 2014; 25 1 45 48
18. Favaloro E. J. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost: 2010; 36 4 458 467
19. Schouten H. J., Geersing G. J., Koek H. L., et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ: 2013; 346 f2492
20. Polo Friz H., Pasciuti L., Meloni D. F., et al. A higher d-dimer threshold safely rules-out pulmonary embolism in very elderly emergency department patients. Thromb Res: 2014; 133 3 380 383
21. Cini M., Legnani C., Frascaro M., Sartori M., Cosmi B., Palareti G. D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units. Int J Lab Hematol: 2014; doi: 10.1111/ijlh.12184
22. Douketis J., Tosetto A., Marcucci M., et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ: 2011; 342 d813
23. Douketis J., Tosetto A., Marcucci M., et al. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med: 2010; 153 8 523 531
24. Ageno W., Squizzato A., Wells P. S., Büller H. R., Johnson G. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost: 2013; 11 8 1597 1602
25. Palareti G., Cosmi B., Legnani C., et al. PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med: 2006; 355 17 1780 1789
26. Legnani C., Palareti G., Cosmi B., Cini M., Tosetto A., Tripodi A.; PROLONG Investigators (FCSA and Italian Federation of Thrombosis Centers). Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. Haematologica: 2008; 93 6 900 907
27. Legnani C., Cini M., Cosmi B., et al. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence. Intern Emerg Med: 2013; 8 3 229 236
28. Baglin T., Palmer C. R., Luddington R., Baglin C. Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors. J Thromb Haemost: 2008; 6 4 577 582
29. Tosetto A., Iorio A., Marcucci M., et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost: 2012; 10 6 1019 1025
30. Ageno W., Dentali F., Donadini M. P., Squizzato A. Optimal treatment duration of venous thrombosis. J Thromb Haemost: 2013; 11 01 151 160
31. Lippi G., Franchini M., Targher G., Favaloro E. J. Help me, Doctor! My D-dimer is raised. Ann Med: 2008; 40 8 594 605
32. Hylek E. M. Anticoagulation therapy for atrial fibrillation. Semin Thromb Hemost: 2013; 39 2 147 152
33. Rojas-Hernandez C. M., Garcia D. A. The novel oral anticoagulants. Semin Thromb Hemost: 2013; 39 2 117 126